Sinopharm Group Co. Ltd. (HKG: 1099)

Sinopharm Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	43,332	63,809	55,222	43,529	50,178	39,192
Short-Term Investments	-	3,330	3,199	2,812	2,633	2,202
Trading Asset Securities	0.55	0.55	0.5	11.75	39.14	0.16
Cash & Short-Term Investments	43,332	67,139	58,421	46,353	52,850	41,394
Cash Growth	26.05%	14.92%	26.04%	-12.29%	27.68%	-1.50%
Accounts Receivable	242,411	185,790	171,204	172,576	146,049	122,629
Other Receivables	-	4,007	3,703	3,698	3,399	3,963
Receivables	242,411	189,797	174,908	176,273	149,448	126,592
Inventory	68,838	60,028	60,926	51,500	47,085	42,594
Restricted Cash	-	1,850	1,488	-	-	-
Other Current Assets	27,782	18,022	23,665	16,796	18,226	19,419
Total Current Assets	382,363	336,835	319,406	290,922	267,610	230,000
Property, Plant & Equipment	20,099	19,898	19,647	19,408	18,896	18,063
Long-Term Investments	10,600	10,551	9,840	9,184	8,473	7,821
Goodwill	-	7,186	7,156	7,199	7,287	5,664
Other Intangible Assets	10,124	2,830	2,941	3,116	3,361	3,258
Long-Term Accounts Receivable	9.79	793.92	1,123	874.58	870	629.78
Long-Term Deferred Tax Assets	2,354	1,964	1,980	1,787	1,602	1,449
Long-Term Deferred Charges	-	180.02	74.44	76.61	81.26	66.35
Other Long-Term Assets	4,034	3,158	2,607	2,845	3,057	2,938
Total Assets	429,583	383,395	364,775	335,412	311,237	269,888
Accounts Payable	155,835	146,632	137,085	128,431	112,632	100,334
Accrued Expenses	34,803	8,832	9,571	8,354	7,760	6,355
Current Portion of Long-Term Debt	79,689	54,730	52,997	55,152	54,959	42,477
Current Portion of Leases	1,761	1,797	1,636	1,548	1,406	1,192
Current Income Taxes Payable	1,077	1,775	1,703	1,614	1,470	1,325
Current Unearned Revenue	6,934	6,399	10,396	6,086	7,324	5,127
Other Current Liabilities	3,139	21,326	21,574	18,122	18,426	21,614
Total Current Liabilities	283,238	241,491	234,963	219,307	203,977	178,425
Long-Term Debt	15,925	13,834	11,750	8,419	8,919	8,373
Long-Term Leases	3,680	3,421	3,207	3,250	3,243	3,097
Long-Term Unearned Revenue	431.34	448.24	493.85	462.74	453.87	433.32
Long-Term Deferred Tax Liabilities	813.24	788.38	936.74	1,023	1,112	1,099
Other Long-Term Liabilities	2,681	2,727	2,975	2,910	3,189	1,123
Total Liabilities	307,150	263,076	254,706	235,758	221,289	192,949
Common Stock	3,121	3,121	3,121	3,121	3,121	2,972
Additional Paid-In Capital	-	24,641	24,641	24,641	24,641	21,223
Retained Earnings	50,399	51,197	44,701	38,516	32,908	27,588
Treasury Stock	-3.84	-3.84	-3.84	-3.84	-3.84	-60.21
Comprensive Income & Other	22,026	-4,373	-4,391	-4,388	-4,308	-4,300
Total Common Equity	75,542	74,582	68,069	61,886	56,359	47,422
Minority Interest	46,891	45,737	42,001	37,768	33,588	29,517
Shareholders' Equity	122,433	120,319	110,069	99,654	89,947	76,939
Total Liabilities & Equity	429,583	383,395	364,775	335,412	311,237	269,888
Total Debt	101,055	73,782	69,590	68,368	68,527	55,139
Net Cash (Debt)	-57,723	-6,643	-11,169	-22,016	-15,677	-13,745
Net Cash Per Share	-18.52	-2.13	-3.58	-7.05	-5.04	-4.63
Filing Date Shares Outstanding	3,121	3,121	3,121	3,121	3,121	2,970
Total Common Shares Outstanding	3,121	3,121	3,121	3,121	3,121	2,970
Working Capital	99,125	95,344	84,443	71,616	63,633	51,575
Book Value Per Share	24.21	23.90	21.81	19.83	18.06	15.97
Tangible Book Value	65,418	64,566	57,972	51,571	45,711	38,500
Tangible Book Value Per Share	20.96	20.69	18.58	16.53	14.65	12.96
Buildings	-	12,997	12,907	12,127	11,346	8,798
Machinery	-	10,099	9,169	8,412	7,605	6,808
Construction In Progress	-	505.47	800.05	718.53	519.85	2,312

Source: S&P Capital IQ. Standard template. Financial Sources.